State of Wisconsin Investment Board’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.55M | Sell |
33,288
-30,095
| -47% | -$1.45M | ﹤0.01% | 1606 |
|
|
2026
Q1 | $3.28M | Sell |
63,383
-1,254
| -2% | -$63.9K | 0.01% | 1160 |
|
|
2025
Q4 | $3.21M | Buy |
64,637
+29,799
| +86% | +$1.45M | 0.01% | 1191 |
|
|
2025
Q3 | $1.66M | Sell |
34,838
-60,376
| -63% | -$2.43M | ﹤0.01% | 1433 |
|
|
2025
Q2 | $3M | Buy |
95,214
+5,019
| +6% | +$161K | 0.01% | 1120 |
|
|
2025
Q1 | $2.95M | Buy |
90,195
+51,741
| +135% | +$1.83M | 0.01% | 1104 |
|
|
2024
Q4 | $1.39M | Sell |
38,454
-56,307
| -59% | -$1.98M | ﹤0.01% | 1409 |
|
|
2024
Q3 | $2.95M | Sell |
94,761
-6,200
| -6% | -$194K | 0.01% | 1157 |
|
|
2024
Q2 | $2.7M | Buy |
100,961
+5,706
| +6% | +$165K | 0.01% | 1181 |
|
|
2024
Q1 | $3.25M | Buy |
95,255
+16,050
| +20% | +$478K | 0.01% | 1109 |
|
|
2023
Q4 | $2.29M | Buy |
79,205
+35,163
| +80% | +$932K | 0.01% | 1211 |
|
|
2023
Q3 | $1.21M | Sell |
44,042
-5,951
| -12% | -$181K | ﹤0.01% | 1348 |
|
|
2023
Q2 | $1.5M | Buy |
49,993
+1,682
| +3% | +$58.9K | ﹤0.01% | 1369 |
|
|
2023
Q1 | $1.75M | Sell |
48,311
-5,360
| -10% | -$206K | 0.01% | 1341 |
|
|
2022
Q4 | $1.91M | Sell |
53,671
-480
| -0.9% | -$16.7K | 0.01% | 1329 |
|
|
2022
Q3 | $1.83M | Sell |
54,151
-3,545
| -6% | -$115K | 0.01% | 1359 |
|
|
2022
Q2 | $1.67M | Sell |
57,696
-11,904
| -17% | -$341K | ﹤0.01% | 1412 |
|
|
2022
Q1 | $2.25M | Hold |
69,600
| – | – | ﹤0.01% | 1463 |
|
|
2021
Q4 | $2.03M | Hold |
69,600
| – | – | ﹤0.01% | 1277 |
|
|
2021
Q3 | $1.86M | Hold |
69,600
| – | – | ﹤0.01% | 1300 |
|
|
2021
Q2 | $2.14M | Hold |
69,600
| – | – | ﹤0.01% | 1269 |
|
|
2021
Q1 | $1.82M | Hold |
69,600
| – | – | ﹤0.01% | 1252 |
|
|
2020
Q4 | $1.75M | Sell |
69,600
-8,700
| -11% | -$187K | ﹤0.01% | 1227 |
|
|
2020
Q3 | $1.63M | Sell |
78,300
-100
| -0.1% | -$2.27K | ﹤0.01% | 1194 |
|
|
2020
Q2 | $1.86M | Sell |
78,400
-3,700
| -5% | -$81.7K | 0.01% | 1142 |
|
|
2020
Q1 | $1.48M | Buy |
82,100
+8,200
| +11% | +$172K | ﹤0.01% | 1130 |
|
|
2019
Q4 | $1.75M | Hold |
73,900
| – | – | ﹤0.01% | 1151 |
|
|
2019
Q3 | $2.03M | Buy |
73,900
+50,700
| +219% | +$1.5M | 0.01% | 1018 |
|
|
2019
Q2 | $768K | Sell |
23,200
-42,000
| -64% | -$1.44M | ﹤0.01% | 1204 |
|
|
2019
Q1 | $2.29M | Buy |
65,200
+14,900
| +30% | +$554K | 0.01% | 977 |
|
|
2018
Q4 | $1.67M | Buy |
50,300
+400
| +0.8% | +$17.2K | 0.01% | 1006 |
|
|
2018
Q3 | $2.51M | Hold |
49,900
| – | – | 0.01% | 998 |
|
|
2018
Q2 | $2.99M | Buy |
49,900
+2,400
| +5% | +$124K | 0.01% | 941 |
|
|
2018
Q1 | $2.17M | Hold |
47,500
| – | – | 0.01% | 960 |
|
|
2017
Q4 | $1.89M | Buy |
47,500
+11,500
| +32% | +$454K | 0.01% | 977 |
|
|
2017
Q3 | $1.44M | Hold |
36,000
| – | – | ﹤0.01% | 1006 |
|
|
2017
Q2 | $1.55M | Buy |
+36,000
| New | +$1.28M | 0.01% | 972 |
|
Other funds holding SUPN
AC
NAMI
SIMG
State of Wisconsin Investment Board's SUPN Position: Q2 2026 in Review
State of Wisconsin Investment Board reduced its Supernus Pharmaceuticals (SUPN) stake by 47% in Q2 2026, selling an estimated $1.45M and leaving 33,288 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1606.
State of Wisconsin Investment Board first reported a position in SUPN in Q2 2017 and has held it in 37 quarters since. The position peaked at $3.28M in Q1 2026. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- State of Wisconsin Investment Board held 33,288 shares of Supernus Pharmaceuticals worth $1.55M as of Q2 2026.
- State of Wisconsin Investment Board sold 30,095 Supernus Pharmaceuticals shares in Q2 2026, an estimated $1.45M.
- Supernus Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1606 holding.
- State of Wisconsin Investment Board first reported a position in Supernus Pharmaceuticals in Q2 2017 and has held it in 37 quarters since.
- State of Wisconsin Investment Board's Supernus Pharmaceuticals position peaked at $3.28M in Q1 2026.
- 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.